Espen Molden

47PUBLICATIONS
203CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)CybercrimeCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jun 28, 2026
Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

|Dec 20, 2025
Antipsychotic load during olanzapine mono- versus polytherapy and in relation to age.

Vigdis Solhaug, Ragnhild Birkeland Waade, Lene Jansrud

|Oct 24, 2025
Meta-analyses of clozapine, norclozapine levels and their ratio across three genome wide association studies.

Susanna Maria Rask, Anssi Solismaa, Ari Ahola-Olli

|Oct 07, 2025
Impact of CYP1A, CYP2C19, CYP2D6, CYP3A4, CYP3A5, and NFIB genotypes on clozapine serum concentration in smokers and nonsmokers.

Hasan Çağın Lenk, Line Skute Bråten, Ole A Andreassen

|Sep 19, 2025
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet Insert.

Georgios Schoretsanitis, Nermine Laaboub, Séverine Crettol

|Aug 09, 2025
Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents.

Karoline Linnea Nordby, Pari Faraj, Espen Molden

Pageof 8

Frequent Collaborators

17 joint publications

Robert Løvsletten Smith

7 joint publications

Magnus Ingelman-Sundberg

6 joint publications

Marianne Kristiansen Kringen

6 joint publications

Hasan Çağın Lenk